醫療用3D技術的全球市場 2015-2021年：企業簡介、市場佔有率、市場趨勢、市場規模、市場機會分析、預測

本報告提供各種3D技術的醫療部門的使用趨勢的相關調查、市場概要、市場成長的各種影響因素分析、醫療用3D技術類型和概要、各種用途、進入經營者的競爭力保持策略、各地區/主要國家趨勢、主要的3D成像及3D列印經營者簡介等彙整資料。

第1章 摘要整理

第2章 市場要素

• 成長推動因素
• 阻礙成長要素
• 市場機會
• 課題

第3章 醫療用3D技術的各種用途

• 3D列印
• 植入
  • 3D列印移植的利用範例
  • 醫療用3D列印的優點
  • 牙科用植入
  • 生物工程
  • 3D列印的生物醫療用途
• 3D列印技術
  • 電子束溶融
  • 薄膜層積
  • 熱感噴墨印刷
  • 選擇性雷射燒結
  • 熱溶解層積 (FDM)
  • 光聚合
• 醫療用3D列印的原料
  • 生物墨水
  • 陶瓷
  • 聚合物
  • ABS
  • PLA
  • 金屬
• 3D成像
  • 3D乳房X光攝影
  • 3D CT
• 虛擬實境
  • 治療中虛擬實境的利用

第4章 醫療用3D技術市場上競爭力保持策略

• 帶來創新的技術的R&D
• 邁向新的3D印刷醫療設備之Stratasys、Worrell的聯盟
• 為了自競爭對手優勢立的收購
  • 案例研究

第5章 地區分析

• 北美
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 法國
  • 德國
• 亞太地區
  • 中國
  • 日本
  • 印度

第6章 企業簡介

• 3D成像
  • GE Healthcare
  • Siemens Healthcare
  • Philips Healthcare
  • 東芝MedicalSystems
  • BARCO NV
  • 日立Medical
    • 概要
    • 產品系列
    • 策略性趨勢
    • SCOT分析等
• 3D列印
  • Stryker
  • 3D Systems Corporation
  • Stratasys
  • Arcam AB
  • Envision TEC GMBH
  • Materialise NV
    • 概要
    • SCOT分析等

圖表

3D technology is one of the fastest growing markets in the world. 3D imaging market is an offshoot of the traditional diagnostic imaging market. Healthcare industry relies increasingly on the 3D imaging market. 3D printing in healthcare is slowly picking up popularity. The companies working on 3D printing technology are new and mainly focused on research and development. Virtual reality in 3D market is still new and being mainly used to treat posttraumatic stress disorders and phobias.

• 3D diagnostic imaging market is more than 80% of the market in the overall 3D healthcare technology market.
• Currently the main players in 3D diagnostic imaging are GE Healthcare, Siemens, Philips, Toshiba and BARCO.
• The market is well established in all the geographies and North America has the largest market share with almost 50% market share.
• The market has two main players in the 3D printing in healthcare, Stratasys and 3D Systems.
• The 3D printing market is growing in the Asia Pacific region. China has been working a lot in the 3D printing market.

This Occams Research Report covers

• 1. Historical data
• 2. Revenue forecasts, growth rates and CAGR upto 2022
• 3. Industry Analysis
• 4. Competitive Analysis
• 5. Key geographic growth data
• 6. Deep profiles top competitive companies

Table of Contents

Chap 1. Executive Summary

Chap 2. Market Determinants

• 2.1. Key Drivers
  • 2.1.1. Better choice over conventional methods
  • 2.1.2. Customized products
  • 2.1.3. Research and Development
  • 2.1.4. Innovative and advanced technologies
  • 2.1.5. FDA nod to 3D innovative technologies
• 2.2. Restraints
  • 2.2.1. High cost to individual patient
  • 2.2.2. Lower Adoption rate
  • 2.2.3. Regulations
• 2.3. Opportunity
  • 2.3.1. Increase in joint replacement surgeries
  • 2.3.2. Medical Tourism
  • 2.3.3. Bio printing technology
• 2.4. Challenges
  • 2.4.1. Transplantation of vital organs
  • 2.4.2. High adoption rate of 3D technology is a challenge
  • 2.4.3. Regulations are a hindrance for 3D technology

Chap 3. 3D technology in healthcare - Application

• 3.1. 3D Printing
• 3.2. Implants
  • 3.2.1. Example of use of 3D printing in implant
  • 3.2.2. Advantages of 3D printing in healthcare
  • 3.2.3. Dental Implants
  • 3.2.4. Bio Engineering
  • 3.2.5. Bio medical applications of 3D printing
• 3.3. 3D printing technologies
  • 3.3.1. Electron beam melting
  • 3.3.2. Laminated object manufacturing
  • 3.3.3. Thermal Inkjet Printing
  • 3.3.4. Selective Laser Sintering
  • 3.3.5. Fused Deposition Modeling (FDM)
  • 3.3.6. Photo polymerization
• 3.4. Raw material used for 3D printing in healthcare
  • 3.4.1. Bio Ink
  • 3.4.2. Ceramic
  • 3.4.3. Polymers
  • 3.4.4. Acrylonitrile Butadiene Styrene (ABS)
  • 3.4.5. Polyactic Acid (PLA)
  • 3.4.6. Metal
• 3.5. 3D Imaging
  • 3.5.1. 3D mammography
  • 3.5.2. 3D computed tomography
• 3.6. Virtual Reality
  • 3.6.1. Use of virtual reality in therapy

Chap 4. Strategies to stay competitive in the 3D technology market in healthcare

• 4.1. Research and development give rise to innovative technologies
• 4.2. Stratasys partners with Worrell for new 3D printed medical devices
  • 4.2.1. Organovo and Johnson & Johnson enter into partnership for 3D bio printing drug discovery research
  • 4.2.2. Organovo enters into partnership with the Yale School of Medicine for 3D bioprinted tissue project
• 4.3. Acquisition gives upper hand over the competitors
  • 4.3.1. Case Study

Chap 5. Geographical analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. Regulations regarding medical devices in Europe
  • 5.2.2. Prevalent diseases in Europe
  • 5.2.3. United Kingdom (UK)
  • 5.2.4. France
  • 5.2.5. Germany
• 5.3. Asia Pacific (APAC)
  • 5.3.1. China
    • 5.3.1.1. Diseases prevalence in China
  • 5.3.2. Japan
  • 5.3.2.1. Regulations in Japan
  • 5.3.3. India

Chap 6. Company Profiling

• 6.1. 3 D Imaging
  • 6.1.1. GE Healthcare
    • 6.1.1.1. Overview
    • 6.1.1.2. Strategic Moves
    • 6.1.1.3. SCOT Analysis
  • 6.1.2. Siemens Healthcare
    • 6.1.2.1. Overview
    • 6.1.2.2. Siemens Healthcare Products Portfolio
    • 6.1.2.3. Strategic Moves (2013-14)
    • 6.1.2.4. SCOT Analysis
  • 6.1.3. Philips Healthcare
    • 6.1.3.1. Overview
    • 6.1.3.2. Phillips Healthcare Products Portfolio
    • 6.1.3.3. Strategic Moves (2013-14)
    • 6.1.3.4. SCOT Analysis
  • 6.1.4. Toshiba Medical Systems
    • 6.1.4.1. Overview
    • 6.1.4.2. Toshiba Medical System Products Portfolio
    • 6.1.4.3. Strategic Moves (2013-14)
    • 6.1.4.4. SCOT Analysis
  • 6.1.5. BARCO NV
    • 6.1.5.1. Overview
    • 6.1.5.2. BARCO NV Products Portfolio
    • 6.1.5.3. Strategic Moves (2013-14)
    • 6.1.5.4. SCOT Analysis
  • 6.1.6. Hitachi Medical Systems
    • 6.1.6.1. Overview
    • 6.1.6.2. Hitachi Medical System Products Portfolio
    • 6.1.6.3. Strategic Moves (2013-14)
    • 6.1.6.4. SCOT Analysis
• 6.2. 3 D Printing
  • 6.2.1. Stryker
    • 6.2.1.1. Overview
    • 6.2.1.2. Strategic Moves (2013-14)
    • 6.2.1.3. SCOT Analysis
  • 6.2.2. 3D Systems Corporation
    • 6.2.2.1. Overview
    • 6.2.2.2. SCOT Analysis
  • 6.2.3. Stratasys
    • 6.2.3.1. Overview
    • 6.2.3.2. SCOT Analysis
  • 6.2.4. Arcam AB
    • 6.2.4.1. Overview
    • 6.2.4.2. SCOT Analysis
  • 6.2.5. Envision TEC GMBH
    • 6.2.5.1. Overview
    • 6.2.5.2. SCOT Analysis
  • 6.2.6. Materialise NV
    • 6.2.6.1. Overview:
    • 6.2.6.2. SCOT Analysis